Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that affects half of all men over the age of 60. Historically, BPH has been treated with medication or an invasive surgical procedure known as transurethral resection of the prostate (TURP). Today, men with BPH have the opportunity to choose a minimally invasive outpatient surgical treatment known as GreenLight™ laser therapy.
About GreenLight™ laser therapy GreenLight™ laser therapy is a minimally invasive surgical treatment option for benign prostatic hyperplasia that combines the effectiveness of TURP, the traditional surgical procedure, with fewer side effects.GreenLight laser therapy uses laser energy to remove enlarged prostate tissue. This results in an open channel for urine to flow through.More than 375,000 patients have been treated with GreenLight laser therapy. The treatment offers a definitive, long-lasting solution for patients with BPH.GreenLight laser therapy’s safety and efficacy has been established in 400 clinical articles and abstracts.Within 24 hours of the procedure, many patients obtain symptom relief and a dramatic improvement in urine flow. Most patients return home a few short hours after the procedure and can return to normal, non-strenuous activities within days.Of the BPH treatment options available, GreenLight has the widest patient selection and is an option for most patients suffering from an enlarged prostate.